Ftse Mib
33.305,46
-1,34%
DAX
19.060,31
-0,60%
S&P 500
5.911,59
0,30%
NASDAQ
18.961,66
0,90%
Bitcoin
93.118,57
2,84%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sage Therapeutics Inc (SAGE) Sage Therapeutics Inc (SAGE) Notizie

Sage Therapeutics Inc

SAGE
4,85
0,07 (1,46%)
Ultimo aggiornamento: 21:12:48
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202420:17EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
01/11/202421:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202421:10EDGAR2Form 8-K - Current report
29/10/202421:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202421:10EDGAR2Form 8-K - Current report
29/10/202421:05BWSage Therapeutics Announces Third Quarter 2024 Financial..
28/10/202415:10PRNUSSage Therapeutics Inc Sued for Securities Law Violations -..
28/10/202410:45PRNUSShareholders that lost money on Sage Therapeutics,..
23/10/202416:00PRNUSSage Therapeutics Inc Sued for Securities Law Violations -..
17/10/202413:11EDGAR2Form 8-K - Current report
17/10/202413:00BWSage Therapeutics Announces Strategic Reorganization to..
17/10/202411:45PRNUSShareholders of Sage Therapeutics, Inc. Should Contact The..
15/10/202412:30BWSage Therapeutics to Report Third Quarter 2024 Financial..
14/10/202411:55PRNUSInvestors who lost money on Sage Therapeutics, Inc.(SAGE)..
10/10/202411:45PRNUSSage Therapeutics, Inc. Securities Fraud Class Action..
08/10/202412:37EDGAR2Form 8-K - Current report
08/10/202412:30BWSage Therapeutics Announces Topline Results from the Phase 2..
07/10/202411:45PRNUSOctober 28, 2024 Deadline: Contact The Gross Law Firm to..
30/9/202411:45PRNUSThe Gross Law Firm Reminds Sage Therapeutics Investors of..
26/9/202413:07EDGAR2Form 8-K - Current report
26/9/202413:00BWSage Therapeutics Announces Discontinuation of the..
26/9/202411:45PRNUSClass Action Filed Against Sage Therapeutics, Inc. (SAGE)..
23/9/202411:45PRNUSThe Gross Law Firm Reminds Sage Therapeutics Investors of..
19/9/202411:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
17/9/202412:33EDGAR2Form S-3ASR - Automatic shelf registration statement of..
16/9/202411:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
12/9/202411:45PRNUSSage Therapeutics, Inc. Class Action: The Gross Law Firm..
05/9/202422:03PRNUSSAGE INVESTOR ALERT: Edelson Lechtzin LLP Urges Sage..
05/9/202414:30PRNUSSage Therapeutics Inc Sued for Securities Law Violations -..
08/8/202416:00PRNUSSage Therapeutics Inc Sued for Securities Law Violations -..
07/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202422:10EDGAR2Form 8-K - Current report
31/7/202422:05BWSage Therapeutics Announces Second Quarter 2024 Financial..
24/7/202412:39EDGAR2Form 8-K - Current report
24/7/202412:30BWSage Therapeutics and Biogen Announce Topline Results from..
17/7/202412:30BWSage Therapeutics to Report Second Quarter 2024 Financial..
11/6/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:16EDGAR2Form 8-K - Current report
11/6/202412:45EDGAR2Form 8-K - Current report
11/6/202412:30BWSage Therapeutics Announces Phase 2 SURVEYOR Study..
05/6/202412:30BWSage Therapeutics to Present at the Goldman Sachs 45th..
07/5/202412:30BWSage Therapeutics to Participate in Upcoming May Investor..
25/4/202412:30BWSage Therapeutics Announces First Quarter 2024 Financial..
17/4/202412:30BWSage Therapeutics Announces Topline Results from Phase 2..
11/4/202412:30BWSage Therapeutics to Report First Quarter 2024 Financial..
28/2/202412:30BWSage Therapeutics to Present at Upcoming March Investor..
Apertura: 4,74 Min: 4,70 Max: 4,95
Chiusura: 4,78

La tua Cronologia

NASDAQ
SAGE
Sage Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network